Clinical trial
PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer
NCT00005916 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00005916 |
|---|---|
| Title | PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer |
| Official title | A Randomized Phase II Study of a PSA-Based Vaccine in Patients With Localized Prostate Cancer Receiving Standard Radiotherapy |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Prostate Cancer, Prostate Neoplasm |
| Intervention type | Drug |
| Interventions | rV-PSA, rF-PSA, rV-B7.1 |
| Enrollment | 48 |
| Start date | Jun 13, 2000 |
| Completion | Dec 22, 2005 |
| First posted | Jun 19, 2000 |
| Last update posted | Jul 2, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: